{"id":"W2104952531","doi":"10.3324/haematol.2014.120220","title":"Vincristine, dexamethasone and epratuzumab for older relapsed/refractory CD22+ B-acute lymphoblastic leukemia patients: a phase II study","year":2014,"lang":"en","type":"letter","venue":"Haematologica","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hotel Dieu Hospital","funders":"National Cancer Institute; Institut National Du Cancer","keywords":"Chemoimmunotherapy; Medicine; Vincristine; Dexamethasone; Internal medicine; Blinatumomab; Oncology; Lymphoblastic Leukemia; Refractory (planetary science); Leukemia; Chemotherapy; Chronic lymphocytic leukemia; Cyclophosphamide; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.0007559609,0.001412625,0.00324622,0.0006880246,0.0006754111,0.000139782,0.0007432199,0.002265519,0.0004087262],"category_scores_gemma":[0.00351795,0.001080809,0.0004593255,0.00048479,0.000690548,0.0001735675,0.0007663915,0.00262885,0.0001821593],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002629553,"about_ca_system_score_gemma":0.001790047,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000106885,"about_ca_topic_score_gemma":0.000005945603,"domain_scores_codex":[0.992259,0.0005460639,0.001542055,0.002307239,0.001587101,0.001758559],"domain_scores_gemma":[0.9926708,0.003152582,0.0008854867,0.001809773,0.0009374288,0.0005438742],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002900516,0.002440538,0.0006110815,0.001633515,0.001318983,0.005646707,0.0004986639,6.424737e-7,0.00005847359,0.00002580648,0.9808006,0.004064517],"study_design_scores_gemma":[0.1044805,0.05058001,0.001495025,0.001389338,0.005583549,0.004273471,0.0002784577,0.002440719,0.000133762,0.000236984,0.8268082,0.002300034],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8797088,0.00104229,0.007208535,0.08841094,0.00151782,0.01777427,0.0009046175,0.001044934,0.002387757],"genre_scores_gemma":[0.5954887,0.0002677854,0.00851934,0.3709018,0.003820602,0.004579798,0.00437301,0.0008449222,0.01120401],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2842201,"threshold_uncertainty_score":0.9998624,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02457267889489427,"score_gpt":0.3097826535611139,"score_spread":0.2852099746662196,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}